Jul 14, 2026
2H2026 Catalyst Cluster
$ABOS, $EPRX, $MSLE, $OVID, $PMN, $XENE
Read piece →$XENE - Encode Coverage
Latest research notes and coverage for $XENE
Mar 20, 2026
Playbooks & Predictions: Xenon, Praxis, and Ovid
Read piece →Sep 3, 2025
Proof of Concept, FDA Alignment, and Durability: Ovid, Rezolute & Eupraxia
Read piece →Jul 17, 2025
Ovid and Xenon: Too Early to Draw Parallels?
$DCTH, $DRUG, $NKTR, $OVID, $PCSA, $SLNO, $XENE
Read piece →May 19, 2025
Decoding Q1: Insights on XENE, DCTH, RNXT, FENC
Read piece →Apr 16, 2025
Franchise Building: Xenon & Delcath
Read piece →Aug 14, 2024
Xenon (XENE), Delcath (DCTH), Protara (TARA) and Other Q2 Musings
$DCTH, $LLY, $NKTR, $PIRS, $TARA, $VERU, $VRTX, $XENE
Read piece →Apr 3, 2024
A Little of Everything, Pain (XENE), Obesity (VERU), Radiopharmaceuticals (CLRB), and a High-Stakes Data Readout
$AZN, $BMS, $CLRB, $DCTH, $FUSN, $LLY, $NKTR, $OPTN, $PNT, $RYZB, $VERU, $VRTX, $XENE
Read piece →Feb 11, 2024